Evidence map›Paper›PMID 18799794›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2008

Kinetic studies of the metabolism of rapidly exchangeable apolipoproteins may leave investigators and readers with exchangeable results.

Henry N Ginsberg, Rajasekhar Ramakrishnan

Abstract readEditorialComment
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Apolipoprotein C3: form begets function.Journal of lipid research · 2024
    Review
  4. Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.Arteriosclerosis, thrombosis, and vascular biology · 2019
    Article
  5. Article
  6. Targeting ApoC-III to Reduce Coronary Disease Risk.Current atherosclerosis reports · 2016
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Henry N Ginsberg
Rajasekhar Ramakrishnan

Funding

CTSA: K12 COMPONENTKL2RR024157 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$8.9M
NCRR NIH HHS KL2 RR024157
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Apolipoprotein C-IIIApolipoproteinsApolipoproteins AApolipoproteins BAtorvastatinCholesterolDown-RegulationDyslipidemiasFenofibrateHeptanoic AcidsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsKineticsLipoproteins, VLDLMaleApolipoprotein C-IIIApolipoproteinsApolipoproteins AApolipoproteins BAtorvastatinCholesterolFenofibrateHeptanoic AcidsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsLipoproteins, VLDLPyrrolesTriglycerides

Identifiers

PMID18799794
PMCPMC3275632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.